Resultados de la búsqueda 11-20 of 3590 for Amphotericin B

1. The world's best hospital - Mayo Clinic

   Play video. Transforming your care. Learn how we drive innovation · Request appointment. Skip this Section. Find diseases & conditions by first letter. A · B.

2. Hematología - Ensayos clínicos - Mayo Clinic

   Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato ...

4. The world's best hospital - Mayo Clinic

   Play video. Transforming your care. Learn how we drive innovation · Request appointment. Skip this Section. Find diseases & conditions by first letter. A · B.

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

8. Hematología - Ensayos clínicos - Mayo Clinic

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and ...